Pluristem Therapeutics, Inc. (NASDAQ:PSTI)

CAPS Rating: 1 out of 5

Recs

0
Player Avatar txboy70 (< 20) Submitted: 8/6/2012 10:28:36 PM : Outperform Start Price: $3.78 PSTI Score: -40.01

biotech has not been as tied to broad market ups and downs.
It is tied to the performance of it's product. PSTI has a product
which has MANY uses,not a one trick poney. It is patented and
is readily repeatable. delivery is simple. the drug stores well in
the typical medical office.

Report this Post Reply

Featured Broker Partners


Advertisement